Blog

Consolidation, Patent Loses, Weak R&D Productivity Depress ITO Transactions in Life Sciences Segment: Everest Group Annual Report Migrate from Outlook Express to Outlook by Britec

Dallas, Texas (PRWEB) October 22, 2013

ITO transaction activity in the life sciences industry slowed markedly in 2012, falling from 82 deals to 54, due to multiple challenges that included patent losses, middling R&D productivity, and rising consolidation.

Smaller life sciences firms ? those with less than US$.

Read more